Northern Trust’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$142K Buy
21,953
+2,350
+12% +$11.3K ﹤0.01% 4026
2026
Q1
$63.7K Hold
19,603
﹤0.01% 4206
2025
Q4
$78K Hold
19,603
﹤0.01% 4186
2025
Q3
$61.2K Hold
19,603
﹤0.01% 4243
2025
Q2
$65.7K Hold
19,603
﹤0.01% 4190
2025
Q1
$82.9K Buy
19,603
+3,891
+25% +$16.1K ﹤0.01% 4149
2024
Q4
$37.2K Sell
15,712
-610
-4% -$899 ﹤0.01% 4303
2024
Q3
$20.9K Hold
16,322
﹤0.01% 4332
2024
Q2
$25K Sell
16,322
-16
-0.1% -$25 ﹤0.01% 4309
2024
Q1
$27.4K Sell
16,338
-1,851
-10% -$3.69K ﹤0.01% 4303
2023
Q4
$32.6K Sell
18,189
-1,635
-8% -$3K ﹤0.01% 4307
2023
Q3
$37.5K Hold
19,824
﹤0.01% 4234
2023
Q2
$29.1K Hold
19,824
﹤0.01% 4337
2023
Q1
$38.7K Buy
19,824
+1,480
+8% +$3.52K ﹤0.01% 4320
2022
Q4
$41.3K Hold
18,344
﹤0.01% 4328
2022
Q3
$45K Hold
18,344
﹤0.01% 4347
2022
Q2
$38K Sell
18,344
-2,273
-11% -$5.26K ﹤0.01% 4478
2022
Q1
$58K Hold
20,617
﹤0.01% 4501
2021
Q4
$96K Buy
20,617
+396
+2% +$1.35K ﹤0.01% 4435
2021
Q3
$55K Hold
20,221
﹤0.01% 4519
2021
Q2
$58K Hold
20,221
﹤0.01% 4464
2021
Q1
$62K Sell
20,221
-1,494
-7% -$4.86K ﹤0.01% 4358
2020
Q4
$64K Sell
21,715
-1,259
-5% -$3.81K ﹤0.01% 4200
2020
Q3
$74K Sell
22,974
-44
-0.2% -$145 ﹤0.01% 4032
2020
Q2
$77K Sell
23,018
-1,730
-7% -$6.29K ﹤0.01% 3972
2020
Q1
$90K Hold
24,748
﹤0.01% 3838
2019
Q4
$128K Hold
24,748
﹤0.01% 3888
2019
Q3
$147K Sell
24,748
-365
-1% -$2.03K ﹤0.01% 3839
2019
Q2
$160K Sell
25,113
-1,216
-5% -$7.37K ﹤0.01% 3867
2019
Q1
$153K Sell
26,329
-898
-3% -$5.21K ﹤0.01% 3831
2018
Q4
$164K Hold
27,227
﹤0.01% 3830
2018
Q3
$156K Buy
27,227
+2,798
+11% +$16.5K ﹤0.01% 3919
2018
Q2
$150K Buy
24,429
+706
+3% +$4.42K ﹤0.01% 3925
2018
Q1
$159K Sell
23,723
-1,152
-5% -$7.93K ﹤0.01% 3877
2017
Q4
$183K Buy
24,875
+611
+3% +$4.5K ﹤0.01% 3840
2017
Q3
$171K Sell
24,264
-1,462
-6% -$10.1K ﹤0.01% 3834
2017
Q2
$180K Hold
25,726
﹤0.01% 3827
2017
Q1
$178K Sell
25,726
-1,701
-6% -$10.3K ﹤0.01% 3829
2016
Q4
$150K Buy
27,427
+1,562
+6% +$8.15K ﹤0.01% 3822
2016
Q3
$129K Buy
25,865
+387
+2% +$1.82K ﹤0.01% 3842
2016
Q2
$115K Sell
25,478
-8,589
-25% -$39.3K ﹤0.01% 3860
2016
Q1
$153K Buy
34,067
+16,182
+90% +$77.1K ﹤0.01% 3811
2015
Q4
$94K Hold
17,885
﹤0.01% 3948
2015
Q3
$104K Sell
17,885
-916
-5% -$5.71K ﹤0.01% 3924
2015
Q2
$134K Sell
18,801
-4,455
-19% -$31K ﹤0.01% 3877
2015
Q1
$155K Sell
23,256
-1,450
-6% -$9.05K ﹤0.01% 3925
2014
Q4
$148K Buy
24,706
+248
+1% +$1.27K ﹤0.01% 3891
2014
Q3
$121K Buy
24,458
+187
+0.8% +$905 ﹤0.01% 3983
2014
Q2
$109K Sell
24,271
-522
-2% -$2.33K ﹤0.01% 3992
2014
Q1
$112K Hold
24,793
﹤0.01% 3918
2013
Q4
$126K Sell
24,793
-100
-0.4% -$488 ﹤0.01% 3826
2013
Q3
$112K Sell
24,893
-91,104
-79% -$454K ﹤0.01% 3792
2013
Q2
$592K Buy
+115,997
New +$577K ﹤0.01% 3420

Other funds holding CPIX

Northern Trust's CPIX Position: Q2 2026 in Review

Northern Trust increased its Cumberland Pharmaceuticals (CPIX) stake by 12% in Q2 2026, buying an estimated $11.3K and bringing the position to 21,953 shares worth $142K. The position accounts for ﹤0.01% of the portfolio, ranked #4026.

Northern Trust first reported a position in CPIX in Q2 2013 and has held it in 53 quarters since. The position peaked at $592K in Q2 2013. 21 funds tracked by Wall St. Rank hold CPIX as of Q2 2026.

  • Northern Trust held 21,953 shares of Cumberland Pharmaceuticals worth $142K as of Q2 2026.
  • Northern Trust bought 2,350 Cumberland Pharmaceuticals shares in Q2 2026, an estimated $11.3K.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4026 holding.
  • Northern Trust first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Northern Trust's Cumberland Pharmaceuticals position peaked at $592K in Q2 2013.
  • 21 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.